# The Study of Ciprofol for the Suppression of Cardiovascular Responses to Tracheal Intubation

> **NCT06095570** · PHASE4 · UNKNOWN · sponsor: **The Second Affiliated Hospital of Hainan Medical University** · enrollment: 150 (estimated)

## Conditions studied

- Intubation, Intratracheal
- Adverse Effects

## Interventions

- **DRUG:** Ciprofol
- **DRUG:** Remimazolam

## Key facts

- **NCT ID:** NCT06095570
- **Lead sponsor:** The Second Affiliated Hospital of Hainan Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-23
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06095570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06095570, "The Study of Ciprofol for the Suppression of Cardiovascular Responses to Tracheal Intubation". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06095570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*